Previous studies by Chen and coworkers using a limited number of prostate cancer samples from the hospital of China Medical University have shown the upregulation of ZIP4 in one-quarter of the cancer samples compared with BPH [117]. The gene discussed is SLC39A4; the disease is prostate cancer.